drugset / Trial / NCT01539317

Therapy to Prevent Sexual Pain in Breast Cancer Survivors

NCT01539317 ↗

Phase 3 Completed 50 enrolled OHSU Knight Cancer Institute
RandomizedCrossoverDouble-blindTreatment

Summary

The purpose of this protocol is to determine whether pain with sexual intercourse can be reduced in menopausal, breast cancer survivors and to evaluate the effectiveness of a non-hormonal therapy (Lidocaine Liquid) vs. a placebo liquid in reducing pain. The investigators hypothesize that the pain arises in the vulvar vestibule. The investigators predict that the localized use of lidocaine will be more efficacious than use of placebo liquid.

Timeline

Start
2011-12
Primary completion
2013-11
Completion
2013-11

Drugs

EvaluationDrugModalityDoseRoute
Comparator Lidocaine Other / unclassified 4 % Topical